Table of Contents Table of Contents
Previous Page  10 / 48 Next Page
Information
Show Menu
Previous Page 10 / 48 Next Page
Page Background

WFSBP 2017

10

Preliminary Scientific Programme Schedule /

Tuesday, 20 June 2017

8:30 S-30

Recent insights

in schizophrenia

physiopathology

and treatments

S-31

Duration of

untreated

psychosis: From

neuroimaging to

clinical trials

S-32

New per-

spectives on

transcranial

magnetic

stimulation

in psychiatric

disorders

S-33

Epigenetic

biomarkers for

the diagnosis of

mood disorders

S-34

Sex hormones

and their

wide-ranging

effects on psy-

chopathology

WS-05

Gesture as

window to

psychosis

pathobiology:

From aberrant

body experience

to social inter-

action

S-35

New insights in-

to the neurobiol-

ogy and treat-

ment aspects of

obsessive com-

pulsive disorder

comorbid with

schizophrenia

and bipolar ...

Free Com-

munications

9:00

9:30

10:00

Plenary Lecture

PL-02

Novel treatments in mood disorders: Molecular mechanisms and clinical applications

10:30

11:00

D-02

The Research

Domain Criteria

(RDoC) can

create a new

kind of taxono-

my holding

greater promise

compared to the

traditional ...

TFS-04

Sleep in

depression and

cognition – from

research to clini-

cal practice

S-36

The role of

the nucleus

accumbens in

psychiatry

S-37

Neurobiologic

imaging

studies of mood

disorders, neu-

rogenetics and

antidepressant

action with posi-

tron emission

tomography

S-38

Treatment resis-

tant schizophre-

nia: Definitions,

psychobiology

and clinical

treatment

WS-06

Neurobiology

of suicidal

behaviour

Free Communications

11:30

12:00

12:30

13:00

Satellite Symposia

13:30

14:00

14:30

15:00

WS-07

Merging

evidence and

clinical practice

in management

of depression:

The CANMAT

experience

TFS-05

Biomarkers

for schizo-

phrenia: From

molecules to

brain function.

A consensus of

the WFSBP Task

Force on biolo-

gical markers

TFW-02

WFSBP Con-

sensus on the

management

of agitation in

psychiatry

S-39

Current research

on the use of

cannabinoids

S-40

Alzheimer's

Disease (AD)

pathophysiolo-

gy, prevention

and treatment

strategies:

Where we stand

and where we

go?

WS-08

Functional neu-

roanatomy of

hallucinations

S-41

Electroconvul-

sive therapy

for depression

– optimising

treatment and

maintaining

recovery

Free Com-

munications

15:30

16:00

16:30

17:00 S-42

Neuroepigenetic

approaches to

assess disease

risk, mechanism

and treatment

TFS-06

Electroconvul-

sive therapy:

Beyond depres-

sion

Satellite Symposia

Free Com-

munications

17:30

18:00

18:30

Registration Counter

08:00–18:30

Poster Exhibition

09:00–17:00

Technical Exhibition

09:00–17:00